Pretreatment of colon cancer cells with the CXCR2 antagonist markedly decreased the stimulatory effect of CXCL2 on tumor cell adhesion to vitronectin, indicating a functional role of CXCR2 on colon cancer cells in CXCL2-induced adhesion. This evidence concerns the gene CXCR2 and neoplasm.